11 Sep 2025
Minimalist approach to tricuspid valve therapy
Sponsored by P&F Products & Features
Anchorperson:
C. Guedes Bezerra
Spokesperson:
A. Ferrero Guadagnoli
Summary
Discover the minimalist approach to tricuspid valve therapy showcased through TricValve implantation, emphasizing a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Review clinical evidence demonstrating reduced hospitalizations, improved quality of life, and favorable mid-term outcomes such as decreased right heart chamber dimensions and reverse flow reduction.
Learning Objectives
- To demonstrate, through a TricValve implantation, how tricuspid regurgitation can be treated using a minimally invasive, contrast-free procedure guided by transthoracic echo (TTE) and requiring minimal fluoroscopy time—resulting in a safe and effective outcome for the patient
- To present TricValve clinical evidence from a self-controlled study showing a reduction in hospitalisation rates and improved quality of life in patients with tricuspid regurgitation
- To highlight mid-term study data showing a reduction in right heart chamber dimensions following TricValve implantation, with significant decrease in reverse flow to the vena cava and improvement in right ventricular pressure
